Cardiology device trials' use of independent clinical committees encouraged by FDA -- ODE's Zuckerman.
This article was originally published in The Gray Sheet
Executive Summary
STUDY BIAS IN "HIGH PROFILE" CARDIOLOGY DEVICE TRIALS should be addressed by independent clinical events committees, FDAers emphasized at a recent Food & Drug Law Institute workshop in Washington, D.C.